SXTP (60 Degrees Pharmaceuticals) Tariff Resilience Score: 5/10 (As of Aug. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SXTP 60 Degrees Pharmaceuticals Inc SXTP
58 GF Score
Price $1.21
GF Value $1.93
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is 60 Degrees Pharmaceuticals Tariff Resilience Score?

60 Degrees Pharmaceuticals SXTP +3.02% 58 Tariff Resilience Score is 5 as of Aug. 16, 2026. GuruFocus rates SXTP with a GF Score™ of 58/100 and a GF Value™ of $1.93 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 1,363 Biotechnology companies, 60 Degrees Pharmaceuticals ranks better than 62.51% on this metric.

60 Degrees Pharmaceuticals has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

60 Degrees Pharmaceuticals has Moderate exposure due to reliance on international suppliers for raw materials. Some mitigation through alternative suppliers, but limited pricing power in generic drug market.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes 60 Degrees Pharmaceuticals might have Average Resilient.

60 Degrees Pharmaceuticals  (NAS:SXTP) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

60 Degrees Pharmaceuticals Tariff Resilience Score Related Terms

SXTP vs GNPX, GLMD, HCWB: Tariff Resilience Score Comparison

For the Biotechnology subindustry, 60 Degrees Pharmaceuticals's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

60 Degrees Pharmaceuticals Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 60 Degrees Pharmaceuticals's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where 60 Degrees Pharmaceuticals's Tariff Resilience Score falls into.


SXTP
58GF Score
60 Degrees Pharmaceuticals Inc SXTP
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
60 Degrees Pharmaceuticals (SXTP) has a Tariff Resilience Score of 5 as of Aug. 16, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, 60 Degrees Pharmaceuticals ranks #511 out of 1363 companies in the Biotechnology industry, placing it in the top 37.5%.
Is 60 Degrees Pharmaceuticals' Tariff Resilience Score too high?
60 Degrees Pharmaceuticals' current Tariff Resilience Score is 5. The Biotechnology industry median Tariff Resilience Score is 4.00. 60 Degrees Pharmaceuticals' value of 5 is 25% above this industry median. Based on the distribution chart, 60 Degrees Pharmaceuticals ranks #511 out of 1363 companies in the Biotechnology industry, which is above the industry midpoint. Overall, 60 Degrees Pharmaceuticals has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does 60 Degrees Pharmaceuticals' Tariff Resilience Score compare to GNPX and GLMD?
According to the Biotechnology industry distribution chart, 60 Degrees Pharmaceuticals ranks #511 out of 1363 companies for Tariff Resilience Score. This puts 60 Degrees Pharmaceuticals in the upper half of its industry. The industry median Tariff Resilience Score is 4.00. 60 Degrees Pharmaceuticals' value of 5 is 25% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,363 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 60 Degrees Pharmaceuticals's current Tariff Resilience Score of 5 is 25% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 60 Degrees Pharmaceuticals's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 60 Degrees Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, 60 Degrees Pharmaceuticals (SXTP) is currently considered Possible Value Trap. The stock's GF Value™ is $1.93, compared to a current price of $1.21 — trading 37.3% below its estimated fair value. The current Tariff Resilience Score is 5 and 25% above the Biotechnology industry median of 4.00. 60 Degrees Pharmaceuticals' overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For 60 Degrees Pharmaceuticals (SXTP), the current Tariff Resilience Score is 5 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 60 Degrees Pharmaceuticals (SXTP) Overvalued in 2026?

Based on GuruFocus' analysis, 60 Degrees Pharmaceuticals stock appears to be undervalued. The current stock price of $1.21 is trading 37.3% below its estimated GF Value™ of $1.93. GuruFocus considers 60 Degrees Pharmaceuticals to be Possible Value Trap.

Key valuation signals for SXTP:

  • Tariff Resilience Score: 5
  • GF Value™: $1.93 vs. price of $1.21 (37.3% below fair value)
  • GF Score™: 58/100 with 5 warning signs
  • Industry Position: 25% above the Biotechnology median (#511 of 1363)

No single metric tells the full story. See the SXTP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

60 Degrees Pharmaceuticals Business Description

Address 1025 Connecticut Avenue NW, Suite 1000, Washington, D.C, WA, USA, 20036
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
58GF Score

Get the complete analysis for SXTP

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.21
Price
$1.93
GF Value